in talks with top 20 bio company, page-15

I beleive its closer to 19 bill p/a now for the top 3 whcih dont work on 30-40% of people anyway.


"Existing RA therapies generate significant income for global pharmaceutical companies - the top 3 therapies generated a combined income of approximately US$17 billion in 2008. 30 to 40% of patients do not respond satisfactorily to these leading therapies. Safety issues exist, and patent expiries present commercial concern for future income streams for big pharmaceuticals"

Anyways another nice day today, was good to some big buyers come in for big lots...am strapped in and enjoying the ride.